A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial.

A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial.

Item
http://www.wikidata.org/entity/Q36407018
Targeting dormant micrometastases: rationale, evidence to date and clinical implicationsHalf-life extended biotherapeutics.Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease SettingsNew therapies for advanced, recurrent, and metastatic endometrial cancers.Peptibodies: An elegant solution for a long-standing problem.Clinical trials in gynecologic oncology: Past, present, and future.BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints.Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection.
P2860

A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial.

Item
http://www.wikidata.org/entity/Q36407018
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A phase II trial of trebananib ...... ecologic Oncology Group trial.
@ast
A phase II trial of trebananib ...... ecologic Oncology Group trial.
@en
type
label
A phase II trial of trebananib ...... ecologic Oncology Group trial.
@ast
A phase II trial of trebananib ...... ecologic Oncology Group trial.
@en
prefLabel
A phase II trial of trebananib ...... ecologic Oncology Group trial.
@ast
A phase II trial of trebananib ...... ecologic Oncology Group trial.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
A phase II trial of trebananib ...... ecologic Oncology Group trial.
@en
P2093
P2860
P304
P31
P356
10.1016/J.YGYNO.2015.07.006
P407
P433
P478
P577
P698
P921
P932